Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
MIRA Pharmaceuticals, Inc. - Common Stock
(NQ:
MIRA
)
1.930
+0.050 (+2.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
535,781
Open
1.930
Bid (Size)
1.860 (4)
Ask (Size)
1.880 (1)
Prev. Close
1.880
Today's Range
1.750 - 1.930
52wk Range
0.5100 - 6.770
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024
August 13, 2024
MIRA stock results show that Mira Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
August 12, 2024
Via
ACCESSWIRE
Performance
YTD
+62.18%
+62.18%
1 Month
+145.55%
+145.55%
3 Month
+127.06%
+127.06%
6 Month
+80.37%
+80.37%
1 Year
-69.17%
-69.17%
More News
Read More
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
August 05, 2024
Via
Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
August 01, 2024
Via
Benzinga
(MIRA) - Analyzing Mira Pharmaceuticals's Short Interest
July 26, 2024
Via
Benzinga
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action
July 25, 2024
Via
ACCESSWIRE
MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year
July 29, 2024
Via
News Direct
Topics
Cannabis
Exposures
Cannabis
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
July 25, 2024
Via
Benzinga
Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?
July 23, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 23, 2024
Via
InvestorPlace
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
July 22, 2024
Via
ACCESSWIRE
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
July 15, 2024
Via
ACCESSWIRE
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 23, 2024
Via
Benzinga
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 23, 2024
Via
Benzinga
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
July 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 22, 2024
Via
Benzinga
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
July 22, 2024
Via
InvestorPlace
Dow Edges Lower; Verizon Shares Fall After Q2 Results
July 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric Disorders
July 22, 2024
Via
Benzinga
Nasdaq Gains 1%; Chicago Fed National Activity Falls In June
July 22, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 15, 2024
Via
Benzinga
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
July 15, 2024
Via
Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
July 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via
Benzinga
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
May 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.